ARCHIVES

Researchers Feel Impact of Shutdown As Grant Review Stops, Funding Runs Dry

This article is from The Cancer Letter archive.

Vol. 22 No. 01 | January 5, 1996

Download PDF Visit The Full Archive

Related Articles

Two Phase II Trials Display Ramucirumab Potential Efficacy

October 26, 2012

NCI, FDA Make Progress On Some Issues, Bu Differences Remain On Endpoints

November 10, 1989

It is The First FDA Withdrawl Of An Accelerated Approval

November 18, 2011

In Brief: Glick, Armitage Lead ASCO; NCAB Approves Resolution Calling For Higher NIH Budget

June 2, 1995

DCT Get Okay to Proceed With Human Cell Line Drug Screening, More Drug Discovery Group

June 19, 1987

ODAC Unanimously Rejects Melblez, Citing Lower Survival

May 17, 2013